ESC Premium Access

New therapies in heart failure with reduced ejection fraction: For whom and when?

Congress Presentation

2 more presentations in this session

Sacubitril valsartan, ivabradine and omecamtic mecarbil.

Speaker: Professor M. Komajda (Paris, FR)

Thumbnail

Vericiguat and SGLT2 inhibitors.

Speaker: Professor C. Lam (Singapore, SG)

Thumbnail

Access the full session

New therapies in heart failure with reduced ejection fraction: For whom and when?

Speakers: Professor M. Komajda, Professor C. Lam
Thumbnail

About the event

Image

ESC Asia with APSC & AFC 2020

3 December - 5 December 2020

Sessions Presentations

Related content

Open Access

Long-term outcomes in PAH: Optimised approach to achieve the best outcomes.

27 August 2021

ESC Premium Access

Efficacy of ARNI in real-world

27 August 2021

ESC Premium Access

TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

27 August 2021

ESC 365 is supported by

logo Novo Nordisk